Who should be vaccinated against human papillomavirus?

International Journal of Gynecological Cancer

Volumn 16, Issue 4, 2006, Pages 1498-1499

  Tjalma, W A A ^a   Van Damme, P ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ANUS CARCINOMA; ANUS INTERCOURSE; BISEXUALITY; CANCER INCIDENCE; CONDYLOMA; HEALTH PROGRAM; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION PREVENTION; MEDICAL DECISION MAKING; PERSISTENT INFECTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SHORT SURVEY; UTERINE CERVIX CANCER; VACCINATION; VIRUS CARCINOGENESIS; VIRUS ETIOLOGY; VIRUS TRANSMISSION; WART VIRUS;

ANUS NEOPLASMS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH POLICY; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 33745933893     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00620.x     Document Type: Short Survey

References (7)

1. Villa LL, Costa RLR, Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
2. Stanley M. The end for genital human papillomavirus infections? Lancet Oncol 2005;6:256-7.
3. Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-65.
4. Tjalma WAA, Van Damme P. Is the public enough aware to accept a vaccination program against human papillomavirus? Vaccine 2005;23:3231.
5. Varnai AG, Bollman M, Griefingholt H, Speich N, Schmitt C, Bollmann R, Decker D. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN) Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis 2006;21:135-42.
6. Geipert N. Vaccinating men for HPV: new strategy for preventing cervical cancer in women? J Natl Cancer Inst 2005;97:630-1.
7. Tjalma WAA, Arbyn M, Paavonen J, van Waes TR, Bogers JJ. Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer 2004;14:751-61.